NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED

About GSTIN 29AACCN6855D1ZA

NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED is a Private Limited Company registered under GST in Karnataka with GSTIN 29AACCN6855D1ZA. The GST registration was obtained on 01 July 2017. The current status of this GST registration is .

The PAN associated with this GSTIN is AACCN6855D. The registration type is Regular. The primary nature of business activities is Others. This GST registration is linked to NOVO RESEARCH PRIVATE LIMITED (CIN: U51397MH2021PTC361406).

GST Registration Details

GSTIN
29AACCN6855D1ZA
PAN Number
Legal Name
NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED
Trade Name
Not Available
Status
GST Type
Regular
State / Jurisdiction
Karnataka (Code: 29)
Entity Type
Private Limited Company
Nature of Business
Others
Registration Date
01 Jul 2017
Principal Place of Business
EMBASSY SQUARE NO.148, UNIT NO.304A AND 304B INFANTRY ROAD INFANTRY ROAD Karnataka

Linked Company Information

CIN
U51397MH2021PTC361406
Company Class
Private
Company Status
Active

Frequently Asked Questions

Is 29AACCN6855D1ZA a valid GST number?

Yes, 29AACCN6855D1ZA is a valid GSTIN registered under the Goods and Services Tax (GST) system in India. It belongs to NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED in Karnataka. The current status of this registration is .

What is the legal name registered under 29AACCN6855D1ZA?

The legal name registered under GSTIN 29AACCN6855D1ZA is NOVOTECH CLINICAL RESEARCH INDIA PRIVATE LIMITED.

What is the PAN linked to 29AACCN6855D1ZA?

The PAN (Permanent Account Number) linked to GSTIN 29AACCN6855D1ZA is AACCN6855D. The first two digits of a GSTIN represent the state code (29 for Karnataka), followed by the 10-character PAN, an entity code, the letter 'Z', and a check digit.

Which company is 29AACCN6855D1ZA linked to?

GSTIN 29AACCN6855D1ZA is linked to NOVO RESEARCH PRIVATE LIMITED (CIN: U51397MH2021PTC361406), a Private company registered in India.

Data last updated: 23 Feb 2026, 14:29 | Record updated: 23 Feb 2026